Opioïdes, business et addiction

This investigative docu-series delves into the complex and devastating opioid crisis, tracing its roots from pharmaceutical industry practices to its profound impact on addiction and communities. Through expert interviews, personal stories, and archival footage, it exposes the powerful forces at play and the human cost of the epidemic.

As a new series set to premiere in 2025, critical reception is not yet available. However, based on the subject matter and the established reputation of its creator, anticipation is high for a rigorous and impactful exploration of the opioid crisis.

• Expected to be a deeply researched and impactful examination of a critical social issue.

• Anticipated to feature compelling personal narratives alongside expert analysis.

• Likely to shed light on the systemic failures that contributed to the opioid epidemic.

Google audience: Audience reception is speculative as the series has not yet aired.

None notable (Series not yet released)

The series aims to be one of the first comprehensive French-language explorations of the global opioid crisis, focusing on its specific manifestations and contributing factors within North America and beyond.